Combretum laurifolium Mart. extract and methods of extracting and using such extract
US7879369B2 · kind B2 · utility
Assignee
Inventors
Key dates
| Filing date | Feb 18, 2008 |
| Grant date | Feb 1, 2011 |
| Priority date | — |
| Expiry date | Feb 18, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2236/51
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of inhibiting COX-2, inhibiting NF-Kappa B activation, treating inflammation, or treating cancer may comprise administering a therapeutically effective amount of an extract of Combretum laurifolium Mart. to a patient. A medicament as described herein may comprise a pharmaceutically acceptable vehicle and a therapeutically effective amount of an extract of Combretum laurifolium Mart. suspended in the vehicle. A method of making an extract of Combretum laurifolium Mart. may comprise creating a component solution by treating Combretum laurifolium Mart. material with an extractor and a solvent and producing an extract by at least partially removing liquid from the component solution. An extract of Combretum laurifolium Mart. may comprise components extracted using various solvents.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.